| Human Gene/Protein |
| MYST3/NCOA2 fusion | 8.4 | |
| SRY (sex determining region Y)-box 3 | 8.4 | |
| FLJ21062 | 8.4 | |
| H2BFM | 8.4 | |
| POM121C | 8.4 | |
| KIAA1099 protein | 8.4 | |
| C6orf80 | 8.4 | |
| ubiquitin specific peptidase 11 | 8.4 | |
| RING3-like protein | 8.4 | |
| Pre-B-cell leukemia homeobox interacting protein 1 | 8.4 | |
| Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide | 8.4 | |
| LQK1 | 8.4 | |
| H2B/S | 8.4 | |
| zinc finger and SCAN domain containing 18 | 8.4 | |
| TCF3-ZNF384 fusion | 8.4 | |
| protein tyrosine phosphatase, receptor type, f polypeptide | 8.4 | |
| FAM160B2 | 8.4 | |
| PAX5/ETV6 fusion | 8.4 | |
| trithorax homolog, Drosophila | 8.4 | |
| Pre-B-cell leukemia homeobox 1 | 8.4 | |
| insulin-stimulated protein kinase 1 | 8.4 | |
| C6orf111 | 8.4 | |
| ELE1-RET | 8.4 | |
| ZFP62 | 8.4 | |
| HERV-E integrase | 8.4 | |
| p27-30 | 8.4 | |
| Interferon gamma receptor 2 | 8.4 | |
| MLL-AF4 fusion protein | 8.4 | |
| HZF16 | 8.4 | |
| TCL3 oncogene | 8.4 | |
| 140 AA | 8.4 | |
| tumor necrosis factor type 1 receptor associated protein | 8.4 | |
| Heat shock 70kDa protein 1B | 8.4 | |
| CRMP1 protein | 8.4 | |
| BMZF-5 | 8.4 | |
| MEF2D/DAZAP1 fusion | 8.4 | |
| WIPF1 protein | 8.4 | |
| pre-B-cell leukemia transcription factor 3 | 8.4 | |
| CYCLIN G2 | 8.4 | |
| TLX1 protein | 8.4 | |
| C3orf54 | 8.4 | |
| RBP2 protein | 8.4 | |
| COMM domain containing 3 | 8.4 | |
| MLL/EB1 | 8.4 | |
| C9orf43 | 8.4 | |
| PI4KAP2 | 8.4 | |
| nuclear factor interleukin 3 regulated | 8.4 | |
| AT rich interactive domain 2 | 8.4 | |
| HBZ protein | 8.4 | |
| CT45A2 | 8.4 | |
| BMZF-2 | 8.4 | |
| IGLJ7 | 8.4 | |
| MTG8b | 8.4 | |
| Heat shock 70kDa protein 4 | 8.4 | |
| LIG3 protein | 8.4 | |
| MLL partner containing FYVE domain | 8.4 | |
| common-site lymphoma/leukemia guanine nucleotide exchange factor | 8.4 | |
| Helios 3 | 8.4 | |
| ASH2L1 | 8.4 | |
| ECT2L | 8.4 | |
| ubiquitin specific peptidase 42 | 8.4 | |
| Minor histocompatibility antigen HA-1 | 8.4 | |
| BCR/ABL p210 fusion protein | 8.4 | |
| FLJ10849 | 8.4 | |
| BMZF-4 | 8.4 | |
| RPP40 | 8.4 | |
| PRO1598 | 8.4 | |
| ZBTB38 protein | 8.4 | |
| pronapsin B | 8.4 | |
| MLF2 protein | 8.4 | |
| pre T-cell antigen receptor alpha | 8.4 | |
| T-cell lymphoma breakpoint-associated target 1 | 8.4 | |
| transmembrane protein 126B | 8.4 | |
| calnexin precursor | 8.4 | |
| TBC1D3G | 8.4 | |
| MRIP-1 | 8.4 | |
| RAET1G2 | 8.4 | |
| BLES03 | 8.4 | |
| mHag HB-1 | 8.4 | |
| putative homeodomain transcription factor 2 | 8.4 | |
| 8.2 kDa differentiation factor | 8.4 | |
| Eukaryotic translation initiation factor 4A, isoform 2 | 8.4 | |
| translational release factor 1 | 8.4 | |
| ZNF254 | 8.4 | |
| LRFN4 | 8.4 | |
| LOC553158 | 8.4 | |
| BCL7A protein | 8.4 | |
| LOH2CR12 | 8.4 | |
| kelch-like 6 | 8.4 | |
| SPIN-2 | 8.4 | |
| CREB3L2-PPARgamma | 8.4 | |
| taspase 1 | 8.1 | |
| E2A/HLF | 8.1 | |
| CCDC28A | 8.0 | |
| translocated to, 3 | 8.0 | |
| MLL protein | 7.9 | |
| GLVR1 | 7.9 | |
| MLL/AF4 | 7.8 | |
| MLL/AF6 fusion | 7.8 | |
| NPA1 | 7.8 | |
| LOH12CR1 | 7.8 | |
| MOZ/CBP | 7.8 | |
| TNG2 | 7.8 | |
| CALM/AF10 fusion | 7.8 | |
| DNA-(apurinic or apyrimidinic site) lyase | 7.8 | |
| SETBP1 protein | 7.8 | |
| HSM-2 | 7.8 | |
| FAM49A | 7.8 | |
| C20orf112 | 7.8 | |
| AF9 | 7.8 | |
| CyP33 | 7.7 | |
| MLL2 protein | 7.7 | |
| PTP-U2 | 7.7 | |
| OTT-MAL | 7.7 | |
| IGLJ2 | 7.7 | |
| HPB-MLT | 7.7 | |
| AML1/MDS1 | 7.6 | |
| TLS-ERG | 7.6 | |
| ETV6 protein | 7.6 | |
| PBXIP1 | 7.6 | |
| AHI-1 | 7.6 | |
| MLLT1 | 7.6 | |
| HRX | 7.6 | |
| HBZ | 7.5 | |
| AKV | 7.5 | |
| EVI-1 | 7.4 | |
| AF10 | 7.4 | |
| PMX1 | 7.4 | |
| ARCN1 protein | 7.4 | |
| Glutathione S-transferase theta 1 | 7.4 | |
| Rho GTPase-activating protein 12 | 7.4 | |
| ZDHHC23 | 7.4 | |
| MRPL21 | 7.4 | |
| zinc finger and AT hook domain containing | 7.4 | |
| FOXD4a | 7.4 | |
| HIP1R protein | 7.4 | |
| alpha-(1,3)-fucosyltransferase | 7.4 | |
| IFN1@ | 7.4 | |
| LTG9 | 7.4 | |
| GLNS | 7.4 | |
| voltage-dependent sodium channel alpha subunit | 7.4 | |
| DOK1 protein | 7.4 | |
| T-cell leukemia/lymphoma 6 | 7.4 | |
| IQ motif containing G | 7.4 | |
| ZNF411 | 7.4 | |
| PBX3 protein | 7.4 | |
| activating signal cointegrator 1 complex subunit 3 | 7.4 | |
| CCR9 chemokine receptor | 7.4 | |
| Bomapin | 7.4 | |
| MLL/MEN | 7.4 | |
| ZNF502 | 7.4 | |
| LGP1 | 7.4 | |
| prostate cancer gene 17 | 7.4 | |
| AT rich interactive domain 5B | 7.4 | |
| protein kinase C, theta | 7.4 | |
| NRIP3 | 7.4 | |
| eyes absent 2 | 7.4 | |
| SMAP-1 | 7.4 | |
| RNA binding motif protein 15 | 7.4 | |
| TU12B1-TY | 7.4 | |
| ZFYVE19 | 7.4 | |
| HLA class II DRB1 antigen | 7.4 | |
| adenylate kinase 3-like 1 | 7.4 | |
| SCAM-1 | 7.4 | |
| WW domain binding protein 1 | 7.4 | |
| HLA-DRB1 protein | 7.4 | |
| C17orf91 | 7.4 | |
| Src activating and signaling molecule | 7.4 | |
| single-stranded DNA binding protein 2 | 7.4 | |
| ALL1-fused gene from chromosome 1q | 7.4 | |
| RBM15 protein | 7.4 | |
| AIF1L | 7.4 | |
| CD297 | 7.4 | |
| MTG8-like protein | 7.4 | |
| RBTN3 | 7.4 | |
| EEN-B2 | 7.4 | |
| MLL/AF10 fusion | 7.4 | |
| Myocyte-specific enhancer factor 2D | 7.4 | |
| FAM62C | 7.4 | |
| FERM and PDZ domain-containing protein 4 | 7.4 | |
| core-binding factor, runt domain, alpha subunit 2 | 7.4 | |
| FLVCR | 7.4 | |
| ALL-1/AF-4 | 7.4 | |
| MYH11 protein | 7.4 | |
| transmembrane channel-like 6 | 7.4 | |
| MXD3 protein | 7.4 | |
| GUCY1B2 | 7.4 | |
| enhancer of polycomb 1 | 7.4 | |
| NudC-like protein | 7.4 | |
| CBP/MOZ | 7.4 | |
| MYC binding protein 2 | 7.4 | |
| ANX8 | 7.4 | |
| cytosolic purine 5'-nucleotidase | 7.4 | |
| KIAA0759 | 7.4 | |
| C-abl | 7.4 | |
| KIAA0128 | 7.4 | |
| EP300 protein | 7.4 | |
| SPINK2 protein | 7.4 | |
| ATL-derived PMA-responsive peptide | 7.4 | |
| Zinc finger protein 804A | 7.4 | |
| H-RAS protein | 7.4 | |
| c6.1A | 7.4 | |
| MLL/AF4 fusion protein | 7.4 | |
| LMO1 protein | 7.4 | |
| MOV10 protein | 7.4 | |
| WD repeat and FYVE domain containing 3 | 7.4 | |
| CLMF | 7.4 | |
| breast carcinoma amplified sequence 3 | 7.4 | |
| WW-domain binding protein 2 | 7.4 | |
| FLJ10298 | 7.4 | |
| MLL | 7.4 | |
| MLLT3 | 7.3 | |
| MLLT10 | 7.3 | |
| putative env | 7.3 | |
| RNA-binding motif protein 15 | 7.3 | |
| ALL-1 | 7.3 | |
| aml1 | 7.2 | |
| AML1 | 7.1 | |
| AF1q | 7.1 | |
| FBL3 | 7.1 | |
| MTG16 | 7.1 | |
| Fms-related tyrosine kinase 3 | 7.1 | |
| RAP1GDS1 | 7.1 | |
| PBX3 | 7.1 | |
| SMMHC | 7.1 | |
| Suppressor of variegation 3-9 homolog 2 | 7.1 | |
| Ribosomal protein S27a | 7.1 | |
| myxovirus resistance protein 2 | 7.1 | |
| TCF3/PBX1 | 7.1 | |
| BCR/ABL fusion protein | 7.1 | |
| DNAJC1 | 7.1 | |
| IP3K-B | 7.1 | |
| minor histocompatibility antigen HA-1 | 7.1 | |
| MLLT2 | 7.1 | |
| MEIS1 | 7.0 | |
| TCL1 | 7.0 | |
| PHF23 | 7.0 | |
| MDS1 | 7.0 | |
| FBL | 7.0 | |
| HOXA9 | 7.0 | |
| LGALS3 protein | 7.0 | |
| Retinoblastoma-binding protein 1 | 7.0 | |
| KMT2A | 7.0 | |
| p30 | 7.0 | |
| ALL | 7.0 | |
| SET binding protein 1 | 7.0 | |
| myeloid/lymphoid or mixed-lineage leukemia | 7.0 | |
| Receptor tyrosine kinase-like orphan receptor 1 | 7.0 | |
| DOT1L | 6.9 | |
| PML/RAR alpha | 6.9 | |
| HOX11 | 6.9 | |
| ETO | 6.9 | |
| bcr/abl | 6.9 | |
| CBFB | 6.9 | |
| breakpoint cluster region | 6.9 | |
| BCR/ABL | 6.8 | |
| PBX1 | 6.8 | |
| JTK5 | 6.8 | |
| stem cell tyrosine kinase 1 | 6.8 | |
| G1 to S phase transition 1 | 6.8 | |
| SCML4 | 6.8 | |
| ZNF93 | 6.8 | |
| WP34 | 6.8 | |
| chromobox homolog 8 | 6.8 | |
| CAB39L | 6.8 | |
| MTG8 protein | 6.8 | |
| RAB2A, member RAS oncogene family | 6.8 | |
| poliovirus receptor-related 3 | 6.8 | |
| Cardiotrophin 1 | 6.8 | |
| Natural killer cell receptor | 6.8 | |
| MTGR1 | 6.8 | |
| MLL3 protein | 6.8 | |
| C13orf18 | 6.8 | |
| NRARP | 6.8 | |
| NBPF14 | 6.8 | |
| ELL3 | 6.8 | |
| GPR172A | 6.8 | |
| AF-17 | 6.8 | |
| WW domain binding protein 5 | 6.8 | |
| Mono(ADP-ribosyl)transferase | 6.8 | |
| MLL/AF4 fusion | 6.8 | |
| H2.0-like homeobox 1 | 6.8 | |
| EFHB | 6.8 | |
| ALL-1 protein | 6.8 | |
| TYKi | 6.8 | |
| KIAA0304 | 6.8 | |
| MTCP-1 | 6.8 | |
| ZNF342 | 6.8 | |
| ACC-6 | 6.8 | |
| growth differentiation factor 1 | 6.8 | |
| TAF(II)70 | 6.8 | |
| SHISA2 | 6.8 | |
| Nomo | 6.8 | |
| ankyrin repeat domain 28 | 6.8 | |
| Axotrophin | 6.8 | |
| transcription factor GATA-5 | 6.8 | |
| Erbb2 interacting protein | 6.8 | |
| bone marrow zinc finger 3 | 6.8 | |
| BLZF1 | 6.8 | |
| GLYATL1 | 6.8 | |
| Ari2 | 6.8 | |
| Mahlavu hepatocellular carcinoma | 6.8 | |
| MLL-TET1 | 6.8 | |
| FPRH1 | 6.8 | |
| SCL protein | 6.8 | |
| KLHDC5 | 6.8 | |
| AIOLOS | 6.8 | |
| protein kinase C, delta | 6.8 | |
| TXBP151 | 6.8 | |
| ELL-associated factor 1 | 6.8 | |
| N4BP2 | 6.8 | |
| HS3ST3A | 6.8 | |
| FMC1 | 6.8 | |
| nonclassical MHC class I antigen | 6.8 | |
| ZNF479 | 6.8 | |
| ZNF257 | 6.8 | |
| synaptotagmin-like 1 | 6.8 | |
| SYTL1 | 6.8 | |
| RUNDC3B | 6.8 | |
| CD37 antigen | 6.8 | |